From Our 2012 Archives
New Guidelines to Help Breast Cancer Survivors
Guidelines Address Gynecologic Side Effects of Cancer Treatment
By Kathleen Doheny
Reviewed by Louise Chang, MD
Feb. 22, 2012 -- When women find out they have breast cancer, many leave their ob-gyn and go to a cancer specialist. After treatment, they return to their ob-gyn.
Although their cancer is gone, cancer-related health issues remain. Concerns about fertility, birth control, menopause, and bone health are common.
If you are one of these estimated 2 million breast cancer survivors in the U.S., your ob-gyn now has new guidance. The American College of Obstetricians and Gynecologists has issued a practice bulletin with new information on how to manage these health issues.
"More and more women are living with breast cancer, and all these [cancer] drugs have gynecologic side effects," says Mindy Goldman, MD, a clinical professor of obstetrics and gynecology and director of the Women's Cancer Care Program at the University of California San Francisco. She developed the report with the ACOG's Committee on Practice Bulletins, Gynecology.
The guidelines are published in Obstetrics & Gynecology.
As more ob-gyns read the new guidelines, "I think women should feel more comfortable in asking questions of their ob-gyns and hopefully get answers," Goldman says.
Breast Cancer Survivors & Gynecology Issues
Breast cancer survivors can have both short-term and long-term side effects, according to the guidelines. Among those:
The guidelines offer options to deal with the issues, based on scientific evidence.
Birth control options, for instance, can include barrier methods such as condoms and diaphragms, the copper IUD, and sterilization, the guidelines say.
The use of the cancer drug tamoxifen is addressed. "It's well-known that tamoxifen can increase uterine cancer risk in postmenopausal women," Goldman tells WebMD. "It turns out it's pretty rare and almost always [occurs] with abnormal bleeding."
For that reason, the guidelines suggest that a routine biopsy and ultrasound are not needed if women past menopause take the drug but do not have bleeding.
Goldman has served as a consultant on hormone therapy and breast cancer risk for Wyeth, which is now part of Pfizer and makes a hormone replacement drug.
Breast Cancer Survivors: Guidelines Should Help Ob-Gyns
The guidelines will be a valuable reminder and update for ob-gyns, says Mark Wakabayashi, MD, MPH, chief of gynecologic oncology at the City of Hope Comprehensive Cancer Center in Duarte, Calif. He reviewed the guidelines for WebMD.
It is difficult for ob-gyns to keep up with how to treat all the side effects of breast cancer, and the new guidelines should help them, he says.
For women returning to their ob-gyn, Wakabayashi gives this advice: "Your physician should be aware of what treatment you are on [or have finished] and the problems."
Before a visit to the ob-gyn, he adds, "Make a list of things that are bothering you." Take it to the visit.
SOURCES: American College of Obstetricians and Gynecologists' Committee on Practice Bulletins, Gynecology, Obstetrics & Gynecology, March 2012.Mindy Goldman, MD, clinical professor of obstetrics and gynecology; director, Women's Cancer Care Program, University of California, San Francisco.Mark Wakabayashi, MD, MPH, chief of gynecologic oncology, City of Hope Comprehensive Cancer Center, Duarte, Calif.